EP3073999
CRYSTALLINE FORM I OF IBRUTINIB
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.11.2014EP published:
30.5.2018EP application number:
14866302.4
EPO information:
European Patent Register
Max expiry date:
25.11.2034
Title:
CRYSTALLINE FORM I OF IBRUTINIB
Timeline
Today
26.11.2014EP application
30.5.2018EP Publication
Owner
Name:
Crystal Pharmatech Co., Ltd.Address:
B4-101 Biobay 218 Xinghu Street Suzhou Industrial Park, 215123, Suzhou, Jiangsu, CN
Name:
Suzhou Pengxu Pharmatech Co., Ltd.Address:
3rd Floor, Building E 2358 ChangAn Road Wujiang, 215200, Suzhou, Jiangsu, CN
Inventor
Name:
CHEN, MinhuaAddress:
Scotch Plains, NJ, US
Name:
ZHANG, YanfengAddress:
SuzhouJiangsu, CN
Name:
YANG, ChaohuiAddress:
SuzhouJiangsu, CN
Name:
ZHANG, XiaoyuAddress:
SuzhouJiangsu, CN
Name:
LU, FeiAddress:
SuzhouJiangsu, CN
Name:
GE, HengAddress:
SuzhouJiangsu, CN
Name:
WANG, PengAddress:
Forest Hills, NY, US
Name:
LI, PixuAddress:
SuzhouJiangsu, CN
Priority
Number:
201310616065Date:
27.11.2013Country:
CN
Number:
201410542609Date:
14.10.2014Country:
CN
Classification
Categories:
A61K 9/48, A61K 31/519, A61P 35/00, C07D 487/04, A61P 35/02